Treatment-resistant depression (TRD) is a mental health challenge that defies conventional therapeutic approaches. Despite efforts to alleviate symptoms through various medications, psychotherapy, and other therapies, some individuals do not respond adequately to standard treatments. The interconnectivity of biological, genetic, and environmental factors contributes to the complexity of this condition. Medical researchers have explored innovative treatments like esketamine and transcranial magnetic stimulation (TMS) to unlock new avenues for patients struggling with treatment-resistant depression.
What is Esketamine for Depression?
Spravato™ Esketamine Therapy is a new solution for patients with treatment-resistant depression (TRD). Approved by the FDA, this prescription medication is administered as a nasal spray at Inspire Behavioral Health’s Spravato Clinic. The active component of Spravato is esketamine, a form of ketamine specifically endorsed for TRD. By using esketamine for depression, Spravato uniquely targets the glutamate system in the brain, rapidly alleviating depressive symptoms within hours or days.
How Spravato Helps Treatment-Resistant Depression
The therapy boasts benefits such as activating neuroplasticity, aiding in processing past negative memories, and exhibiting no long-term side effects or addiction risks. Spravato can induce short-lived side effects such as dizziness and dissociation, but patients are closely monitored for approximately two hours. Beyond esketamine for depression, Spravato shows promise in treating conditions like PTSD, OCD, anxiety, and eating disorders.
Finding Spravato Treatment Near Me
For patients seeking treatment with esketamine for depression, you have found the best Spravato treatment near me. The treatment protocol at Inspire Behavioral Health involves supervised nasal spray administration. You will start with two clinic visits per week for the first four weeks, followed by once-a-week or bi-weekly sessions. Spravato is only for individuals aged 18 or older who exhibit inadequate responses or intolerance to at least two antidepressants.
Individuals considering Spravato therapy are encouraged to consult with their providers to customize a treatment plan tailored to their unique needs. Contact Inspire Behavioral Health at 703-592-4600 and take a step towards transformative care.